ClinicalTrials.gg
CompletedNCT03331809Updated Mar 18, 2019

Two Handed Jaw-thrust on Postoperative Sore Throat After Double-lumen Endotracheal Tube Insertion

An interventional study of Two-handed jaw thrust and Conventional intubation in Lung Surgery, sponsored by Keimyung University Dongsan Medical Center. Completed at 1 site in Korea, Republic of. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2019-03-18.

Primary conditionPharyngitis(the registry's first term)UnverifiedIs this wrong?The registry often attaches Pharyngitis to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Keimyung University Dongsan Medical Center · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
106
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This investigation is planned to compare the incidence and severity of postoperative sore throat according to the use of two-handed jaw thrust maneuver in patients undergoing double-lumen endotracheal intubation.

02

Conditions studied

  • Lung Surgery

Browse trials for

Keywords

  • intubation
  • pharyngitis
03

In context

Pharyngitis Unverified

226 studies on the registry are indexed under Pharyngitis; 35 are open to participants now.

This study's enrollment of 106 is below the median of 144 across 188 interventional studies indexed under Pharyngitis.

Browse Pharyngitis studies →

Lead sponsor

Keimyung University Dongsan Medical Center is the lead sponsor of 86 studies on the registry; 11 are open to participants now.

Compared within Pharyngitis, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients scheduled for double-lumen endotracheal intubation

Exclusion criteria

Exclusion Criteria:

  • Difficult airway
  • Mallampatti scores greater than 3
  • Recent sore throat
  • Cervical spine disease
  • History of head and neck surgery
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
106 participants (actual)

Study arms

  • Active comparator
    Control

    Procedure: Conventional intubation

  • Experimental
    Two-hand

    Procedure: Two-handed jaw thrust

Interventions

  • ProcedureTwo-handed jaw thrust

    The assistant applied two-handed jaw thrust when intubating with double-lumen tube endotracheal tube.

  • ProcedureConventional intubation

    The attending anesthesiologist provided intubation with double-lumen tube endotracheal tube without two-handed jaw thrust.

06

What researchers measure

Primary outcomes

  1. Number of participants with postoperative sore throat for postoperative 24 h

    Time frame: At 24 hr

Secondary outcomes

  1. Number of participants with postoperative sore throat

    Time frame: At 1, 6, and 24 hr

  2. Postoperative sore throat scores

    Visual anlogue scales will be used (10: most imaginable pain, 0: no pain).

    Time frame: At 1, 6, and 24 hr

  3. Number of participants with postoperative hoarseness

    Time frame: At 1, 6, and 24 hr

  4. Number of participants with postoperative shivering

    Time frame: At 1, 6, and 24 hr

  5. Wound pain scores

    Visual anlogue scales will be used (10: most imaginable pain, 0: no pain).

    Time frame: At 1, 6, and 24 hr

  6. Jaw discomfort scores

    Visual anlogue scales will be used (10: most imaginable pain, 0: no pain).

    Time frame: At 1, 6, and 24 hr

07

Study locations

1 site
  • Keimyung University
    Daegu, Non-US/Canada 137-040, Korea, Republic of
08

References and documents

Publications

  • Park JJ, Huh H, Yoon SZ, Lim HJ, Go DY, Cho JE, Lee J, Park J, Kim HC. Two-handed jaw thrust decreases postoperative sore throat in patients undergoing double-lumen endobronchial intubation: A randomised study. Eur J Anaesthesiol. 2020 Feb;37(2):105-112. doi: 10.1097/EJA.0000000000001149. PubMed 31860598 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 18, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03331809
Lead sponsor
Keimyung University Dongsan Medical Center
Responsible party
Sponsor
First posted
Nov 6, 2017
Start date
Dec 11, 2017
Primary completion
May 1, 2018
Completion
May 2, 2018
Last update
Mar 18, 2019

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion